Ani Pharmaceuticals (ANIP) Interest & Investment Income: 2010-2025
Historic Interest & Investment Income for Ani Pharmaceuticals (ANIP) over the last 14 years, with Sep 2025 value amounting to -$4.7 million.
- Ani Pharmaceuticals' Interest & Investment Income fell 102.79% to -$4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$21.7 million, marking a year-over-year decrease of 24.99%. This contributed to the annual value of -$17.6 million for FY2024, which is 34.66% up from last year.
- As of Q3 2025, Ani Pharmaceuticals' Interest & Investment Income stood at -$4.7 million, which was up 13.07% from -$5.4 million recorded in Q2 2025.
- In the past 5 years, Ani Pharmaceuticals' Interest & Investment Income registered a high of -$2.3 million during Q3 2024, and its lowest value of -$7.7 million during Q1 2023.
- Moreover, its 3-year median value for Interest & Investment Income was -$5.5 million (2025), whereas its average is -$5.5 million.
- Per our database at Business Quant, Ani Pharmaceuticals' Interest & Investment Income tumbled by 190.91% in 2022 and then skyrocketed by 63.57% in 2024.
- Quarterly analysis of 5 years shows Ani Pharmaceuticals' Interest & Investment Income stood at -$4.4 million in 2021, then crashed by 69.05% to -$7.5 million in 2022, then rose by 23.45% to -$5.7 million in 2023, then dropped by 4.68% to -$6.0 million in 2024, then crashed by 102.79% to -$4.7 million in 2025.
- Its last three reported values are -$4.7 million in Q3 2025, -$5.4 million for Q2 2025, and -$5.5 million during Q1 2025.